Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2008
02/28/2008WO2007127428A3 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
02/28/2008WO2007120522A3 Permuted and nonpermuted luciferase biosensors
02/28/2008WO2007103282A3 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
02/28/2008WO2007056760A3 Hcv-reactive t cell receptors
02/28/2008US20080052792 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
02/28/2008US20080052788 Alfalfa Plants Having Improved Standability and Methods for Producing Same
02/28/2008US20080052787 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
02/28/2008US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods
02/28/2008US20080051412 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds and their Uses
02/28/2008US20080051372 Methods utilizing cell-signaling lysophospholipids
02/28/2008US20080051371 Membrane permeable; ischemia, heart failure, and neurodegenerative disorders
02/28/2008US20080051362 Breast and prostate cancer; antisense oligodeoxynucleotides as antiproliferative agents; apoptosis
02/28/2008US20080051356 Truncated 24kDa basic fibroblast growth factor
02/28/2008US20080051354 Human schwannoma cell line
02/28/2008US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
02/28/2008US20080051342 TRPS1-mediated modulation of hair growth
02/28/2008US20080051338 98 Human Secreted Proteins
02/28/2008US20080051334 Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases
02/28/2008US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
02/28/2008US20080051318 Detecting single nucleotide polymorphism ; kits; drug screening; neurodegenerative disease
02/28/2008US20080051317 Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
02/28/2008US20080050840 Novel protein kinase molecules and uses therefor
02/28/2008US20080050825 Method for Production of Transgenic Plants with Increased Pathogenic Resistance by Altering the Content and/or Activity of Actin-Depolymerising Factors
02/28/2008US20080050821 Alfalfa Plants Having Improved Fast Recovery After Harvest and Methods for Producing Same
02/28/2008US20080050820 Casein kinase stress-related polypeptides and methods of use in plants
02/28/2008US20080050819 Constructs for Marker Excision Based on Dual-Function Selection Marker
02/28/2008US20080050817 Basal Medium For Es Culturing
02/28/2008US20080050816 Cell culture chip with a III-V nitride compound adhesion layer and applied thereof
02/28/2008US20080050815 Method of oocyte cryopreservation including piercing the zona pellucida prior to vitrification
02/28/2008US20080050814 Procurement, isolation and cryopreservation of fetal placental cells
02/28/2008US20080050813 Derivation And Culture Of Human Embryo-Derived Cells
02/28/2008US20080050812 Micropositioning Cells For Tissue Engineering
02/28/2008US20080050811 Testicular carnitine transporter and its gene
02/28/2008US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
02/28/2008US20080050809 Novel human kinases and polynucleotides encoding the same
02/28/2008US20080050799 Liquid crystals with reduced toxicity and applications thereof
02/28/2008US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders
02/28/2008US20080050796 Polyketide synthetase activity; vectors; host cells
02/28/2008US20080050794 Optoinjection methods
02/28/2008US20080050791 Pufa polyketide synthase systems and uses thereof
02/28/2008US20080050790 Pufa polyketide synthase systems and uses thereof
02/28/2008US20080050788 Gamma-Butyrobetaine Hydroxylase Originated From Neurospora Crassa
02/28/2008US20080050777 Methods for Expression and Purification of Recombinant Human Growth Hormone
02/28/2008US20080050775 Methods for Recovering Products From Plants
02/28/2008US20080050770 Method for the production and purification of adenoviral vectors
02/28/2008US20080050766 Plasmid Having Response to Dioxins, Transgenic Cell for Measuring Dioxins, Dioxins Sensing Method and Biosensor Using the Same
02/28/2008US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection
02/28/2008US20080050746 Nucleic acid quantitation from tissue slides
02/28/2008US20080050745 Sugar chain synthesizing agent having beta1,3-N-acetyglucosaminyltransferase activity
02/28/2008US20080050716 Methods for preserving organs and tissues
02/28/2008US20080050506 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase
02/28/2008US20080050505 Phosphopantetheinyl transferases from bacteria
02/28/2008US20080050460 Uses of lectin-conotoxin
02/28/2008US20080050416 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject
02/28/2008US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection
02/28/2008US20080050401 Rescue of Influenza Virus
02/28/2008US20080050389 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
02/28/2008US20080050381 Antihuman Baff Antibody
02/28/2008US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents
02/28/2008US20080050370 Stabilized polypeptide compositions
02/28/2008US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith
02/28/2008US20080050367 Humanized antibodies that recognize beta amyloid peptide
02/28/2008US20080050365 Anti-Hiv Antibody
02/28/2008US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism
02/28/2008US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder
02/28/2008US20080050349 Cell based therapy for the pulmonary system
02/28/2008US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
02/28/2008US20080050343 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same
02/28/2008US20080050342 Genetic inhibition by double-stranded RNA
02/28/2008US20080050341 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival
02/28/2008US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
02/28/2008US20080050313 Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use
02/28/2008US20080050311 Monoclonal Antibody hPAM4
02/28/2008US20080050310 Antibodies and immunoconjugates and uses therefor
02/28/2008US20080048327 Electronic circuit with embedded memory
02/28/2008US20080048052 Spray Nozzle Apparatus and Method of Use
02/28/2008DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use
02/28/2008DE102006040043A1 Heteromyeloma cell useful for trioma production comprises a complete murine genome and six human chromosomes
02/28/2008CA2663948A1 Pullulanase variants with increased productivity
02/28/2008CA2661647A1 Method for highly amplifying target gene in mammalian cell and vector therefor
02/28/2008CA2661492A1 Hcv fusion polypeptides
02/28/2008CA2661468A1 Tissue culture system for production of hepatitis c virus
02/28/2008CA2660518A1 Manufacturing method of activated lymphocytes for immunotherapy
02/28/2008CA2660156A1 Anti-c5ar antibodies with improved properties
02/28/2008CA2659993A1 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
02/28/2008CA2643356A1 Synthetic genomes
02/27/2008EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
02/27/2008EP1892294A1 Method for transfer of gene into fat cell or progenitor fat cell
02/27/2008EP1892292A2 Recombinant bacterial phytases and uses thereof
02/27/2008EP1892290A1 Method of differentiation induction to osteoblasts
02/27/2008EP1892289A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
02/27/2008EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/27/2008EP1892250A2 CYR61 compositions and methods
02/27/2008EP1892246A2 Antimicrobial peptides and method for identifying and using such peptides
02/27/2008EP1891209A1 Means and methods for generating a t cell against an antigen of interest.
02/27/2008EP1891208A2 Novel cellular compositions and methods for their preparation
02/27/2008EP1891207A2 Process for cultivating animal cells comprising the feeding of plant-derived peptones
02/27/2008EP1891206A1 Mass production of secondary metabolite in plant cell culture by treatment of saccharide mixture in medicum
02/27/2008EP1891205A1 Suspension culture vessels
02/27/2008EP1891204A1 Method of fetal cell enrichment